User login

Join The Debate

Cast your vote and join the conversation.

Membership is free.

Get Started

You are here

Lori Reilly

Lori Reilly

Executive VP for Policy, Research, and Membership, PhRMA
Lori M. Reilly is executive vice president for policy, research and membership at the Pharmaceutical Research and Manufacturers of America (PhRMA). Reilly heads PhRMA’s policy and research department in the development and implementation of legislative, regulatory, and political strategies to successfully navigate the ever-changing federal health care landscape, working to advance policies that encourage medical progress and patient access to the fruits of pharmaceutical innovation. In her membership role, Reilly leads the association’s efforts to grow the depth and breadth of innovative pharmaceutical company membership and engagement.  Prior to joining PhRMA, she was counsel at the U.S. House of Representatives Committee on Commerce. And before joining the House Commerce Committee, Reilly was chief of staff/counsel to Rep. Jon Christensen, a member of the House Ways and Means Committee.  

More About Lori Reilly

During a panel on drug costs, Reilly explains how the profits from drug sales allow for manufacturers to recoup the high R&D costs of new products, as well as contribute to facilitating further innovations and breakthroughs. (Reilly speaks at 26:16) 

Friday, September 18, 2015
Reilly discusses rising drug costs, especially for specialty drugs, and the need to do more to reduce prices.
Thursday, May 28, 2015

Profile of Lori Reilly’s work as executive vice president for policy and research at the Pharmaceutical Research and Manufacturers of America (PhRMA). 

Tuesday, July 22, 2014

Pharmaceutical Research and Manufacturers of America's overview of the cost and value of medicines.